CJC-1295 5mg

A synthetic analog of growth hormone-releasing hormone (GHRH) with enhanced plasma stability, CJC-1295 is widely utilized in endocrinology research exploring pulsatile GH secretion patterns.

Molecular Weight

3649.30 g/mol

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

$129.99

Lab Tested

99%+ Purity

Fast Shipping

Molecular Formula

C165H271N47O46

Molecular Weight

3649.30 g/mol

Purity

98.5%

CAS Number

863288-34-0

Half Life

6-8 days (with DAC), 30 minutes (without DAC)

Storage

-20°C

Administration

subcutaneous

Research Status

phase2

View on PubChem

Description Research Mechanism Benefits Dosage Safety

Description

CJC-1295 is a tetrasubstituted 30-amino acid peptide analog of growth hormone-releasing hormone (GHRH 1-29). Through strategic amino acid modifications, this compound exhibits significantly extended biological half-life compared to native GHRH, making it an invaluable tool for researchers studying sustained growth hormone axis modulation in laboratory settings. Research literature suggests that CJC-1295 interacts with GHRH receptors in pituitary tissue, potentially influencing growth hormone secretion patterns. Scientific studies have examined its effects on IGF-1 expression, body composition parameters, and metabolic markers in various animal models. Research Applications Endocrine system studies Growth hormone secretagogue research Metabolic investigations Body composition analysis Pituitary function research For laboratory and scientific research purposes only.

Research

CJC-1295 is a synthetic GHRH analog studied for: - Growth hormone deficiency treatment - Age-related hormone decline - Body composition improvement - Muscle growth and recovery - Fat loss research - Sleep quality improvement - Cognitive function enhancement - Anti-aging research

Mechanism

CJC-1295 functions by: 1. Binding to GHRH receptors on pituitary somatotrophs 2. Stimulating cAMP production 3. Triggering growth hormone release 4. Extended half-life through DAC technology 5. Preserving natural GH pulsatile secretion 6. Enhancing IGF-1 production 7. Negative feedback loop preservation

Benefits

Increased growth hormone production Enhanced IGF-1 levels Improved body composition Increased muscle mass Reduced body fat Better sleep quality Enhanced recovery Improved skin elasticity Increased bone density

Dosage

Research protocols typically use: - With DAC: 1-2mg once or twice weekly - Without DAC: 100-200mcg daily - Timing: Evening administration preferred - Cycle: 8-12 weeks on, 4 weeks off - Best taken on empty stomach

Safety

Potential side effects include: - Injection site reactions - Temporary fatigue - Headaches - Dizziness - Flushing - Vivid dreams - Temporary hypoglycemia - Water retention (mild)